TORILL P NELSON
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family CAMDEN, SC NPI 1720032485
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family SC ABBVIE INC. All categories
General Payments — all program years on this page
$6,042.05
- Category: General Payments
- Program years: PY2021–2024
- Record count: 339
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,349.70 across 73 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,259.70 | 72 |
| Education | $90.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $340.56 | 19 |
| Astellas Pharma US Inc | $154.31 | 5 |
| PFIZER INC. | $125.03 | 7 |
| Amgen Inc. | $109.93 | 5 |
| Novo Nordisk AS | $101.76 | 7 |
| Abbott Laboratories | $65.46 | 4 |
| Lilly USA, LLC | $57.76 | 4 |
| GlaxoSmithKline, LLC. | $48.25 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $45.87 | 3 |
| McKesson Medical-Surgical, Inc. | $40.96 | 1 |
| Exact Sciences Corporation | $35.37 | 2 |
| Acerta Pharma LLC | $33.88 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $33.83 | 2 |
| Daiichi Sankyo Inc. | $22.00 | 1 |
| Corcept Therapeutics | $20.53 | 1 |
| Seqirus USA Inc | $19.58 | 1 |
| Merck Sharp & Dohme Corporation | $17.47 | 1 |
| Antares Pharma, Inc. | $16.94 | 1 |
| Insulet Corporation | $16.31 | 1 |
| ITI, Inc. | $15.32 | 1 |
| Phathom Pharmaceuticals, Inc. | $14.37 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.21 | 1 |
By program year
Records — PY2024 (73)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.